Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Relay Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 14 filings
- 5 insiders, $121.7M in total
- Insiders trading
- 5
- Net value
- −$121.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Relay Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bergstrom Donald A | President, R&D | 399,130 | Sep 9, 2026 | 8 |
| Catinazzo Thomas | Chief Financial Officer | 122,851 | Sep 9, 2026 | 12 |
| Patel Sanjiv | President and CEO | 519,500 | Sep 9, 2026 | 6 |
| Rahmer Peter | See remarks | 223,657 | Aug 28, 2026 | 7 |
| SB Investment Advisers (UK) Ltd | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| Softbank Vision Fund (Aiv M2) L.P. | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| SVF Pauling (Cayman) Ltd | 10% Owner | 21,904,963Indirect | Aug 28, 2026 | 1 |
| Hill Linda A | Director | – | Jun 10, 2026 | 1 |
| Ingram Douglas S | Director | – | Jun 10, 2026 | 1 |
| Borisy Alexis | Director | – | Jun 10, 2026 | 1 |
| Coats Lonnel | Director | – | Jun 10, 2026 | 2 |
| Dable Habib J | Director | – | Jun 10, 2026 | 2 |
| Murcko Mark | Director | 996,952 | Jun 10, 2026 | 1 |
| Mazumdar Claire | Director | – | Jun 10, 2026 | 1 |
| Adams Brian | Chief Legal Officer | 371,472 | Jul 30, 2025 | 0 |
| Rubin Jami | Director | 67,242 | Jun 6, 2025 | 0 |
| Kathiresan Sekar | Director | – | Jun 6, 2025 | 0 |
| Shawver Laura | Director | 40,000 | Jun 5, 2024 | 0 |
| Porter Andy | Chief Administrative Officer | 45,164 | Nov 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2022 (view filing) | Jun 27 | 1 day | Adams BrianChief Legal Officer | SSale | −300 | $20.31 | −$6.09K | −0.5%63.6K after | |
| Jun 28, 2022 (view filing) | Jun 24-27 | 4 days | Bergstrom Donald APresident, R&D | SSale | −9.00K | $20.03 | −$180.3K | −9.0%91.5K after | 2 lots |
| May 2, 2022 (view filing) | Apr 28-May 2 | 4 days | Bergstrom Donald APresident, R&D | SSale | −14.8K | $24.74 | −$366.4K | −13.8%92.5K after | 2 lots |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Porter AndyChief Administrative Officer | SSale | −435 | $25.57 | −$11.1K | −0.9%46.6K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Catinazzo ThomasChief Financial Officer | SSale | −725 | $25.57 | −$18.5K | −1.3%53.3K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Adams BrianChief Legal Officer | SSale | −708 | $25.57 | −$18.1K | −1.1%63.9K after | |
| Apr 14, 2022 (view filing) | Apr 12-14 | 2 days | Patel SanjivPresident and CEO | SSale | −84.0K | $31.42 | −$2.64M | −24.9%253.7K after | 5 lots |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Bergstrom Donald APresident, R&D | SSale | −18.0K | $30.32 | −$545.8K | −16.0%94.3K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Porter AndyChief Administrative Officer | SSale | −294 | $29.87 | −$8.78K | −0.6%47.0K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Catinazzo ThomasChief Financial Officer | SSale | −282 | $29.87 | −$8.42K | −0.5%54.0K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Bergstrom Donald APresident, R&D | SSale | −622 | $29.87 | −$18.6K | −0.7%94.3K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Adams BrianChief Legal Officer | SSale | −333 | $29.87 | −$9.95K | −0.5%64.6K after | |
| Mar 28, 2022 (view filing) | Mar 24 | 4 days | Catinazzo ThomasChief Financial Officer | SSale | −13.3K | $30.00 | −$398.6K | −19.7%54.3K after | |
| Mar 28, 2022 (view filing) | Mar 24 | 4 days | Bergstrom Donald APresident, R&D | SSale | −10.0K | $30.00 | −$300.0K | −9.5%94.9K after | |
| Mar 11, 2022 (view filing) | Mar 10 | 1 day | Bergstrom Donald APresident, R&D | SSale | −10.0K | $25.00 | −$250.0K | −9.5%94.9K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Bergstrom Donald APresident, R&D | SSale | −8.00K | $23.88 | −$191.0K | −7.8%94.9K after | |
| Feb 22, 2022 (view filing) | Feb 22 | Same day | Bergstrom Donald APresident, R&D | SSale | −23.0K | $20.94 | −$481.6K | −19.5%94.9K after | 3 lots |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Porter AndySee Remarks | SSale | −260 | $33.10 | −$8.61K | −1.1%23.1K after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Catinazzo ThomasSenior Vice President, Finance | SSale | −295 | $33.10 | −$9.76K | −1.9%15.0K after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Bergstrom Donald ASee Remarks | SSale | −649 | $33.10 | −$21.5K | −1.4%45.0K after | |
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Adams BrianGeneral Counsel | SSale | −295 | $33.10 | −$9.76K | −1.2%25.0K after | |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Catinazzo ThomasSenior Vice President, Finance | SSale | −22.5K | $35.40 | −$796.5K | −59.5%15.3K after | |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Adams BrianGeneral Counsel | SSale | −6.50K | $35.42 | −$230.2K | −20.5%25.3K after | |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Bergstrom Donald ASee Remarks | SSale | −30.0K | $34.15 | −$1.02M | −39.7%45.6K after | |
| Sep 27, 2021 (view filing) | Sep 27 | Same day | Catinazzo ThomasSenior Vice President, Finance | SSale | −293 | $36.87 | −$10.8K | −1.9%15.3K after | |
| Sep 27, 2021 (view filing) | Sep 27 | Same day | Bergstrom Donald ASee Remarks | SSale | −646 | $36.87 | −$23.8K | −0.8%75.6K after | |
| Sep 27, 2021 (view filing) | Sep 27 | Same day | Adams BrianGeneral Counsel | SSale | −293 | $36.87 | −$10.8K | −1.1%25.3K after | |
| Sep 13, 2021 (view filing) | Sep 13 | Same day | Adams BrianGeneral Counsel | SSale | −6.50K | $35.02 | −$227.6K | −20.3%25.6K after | |
| Sep 13, 2021 (view filing) | Sep 13 | Same day | Catinazzo ThomasSenior Vice President, Finance | SSale | −22.5K | $35.00 | −$787.5K | −59.1%15.6K after |